batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Olema set for an operatic debut at last 2 December 2024 Senti tries to buck the Car-NK trend 2 December 2024 Eikon becomes a pivotal-stage biotech 2 December 2024 Kelun hits dato-dxd while it's down 28 November 2024 Cabometyx’s Cabinet committee 27 November 2024 Merck gets high with subcutaneous Keytruda 27 November 2024 EU backs Tevimbra's stomach restriction – and then some 27 November 2024 Roche’s Skyscraper crumbles 26 November 2024 Load More